Victory Capital Management
CMPX icon

Victory Capital Management’s Compass Therapeutics CMPX Stock Holding History

Victory Capital Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.6K Sell
13,729
-582
-4% -$3.36K ﹤0.01% 2293
2025
Q4 		$76.8K Buy
14,311
+1,659
+13% +$7.66K ﹤0.01% 2297
2025
Q3 		$44.3K Buy
12,652
+2,164
+21% +$6.83K ﹤0.01% 2351
2025
Q2 		$27.3K Buy
+10,488
New +$21.6K ﹤0.01% 2424
2025
Q1 		– Sell
-10,536
Closed -$15.3K – 2487
2024
Q4 		$15.3K Sell
10,536
-356
-3% -$591 ﹤0.01% 2458
2024
Q3 		$20K Sell
10,892
-573
-5% -$714 ﹤0.01% 2443
2024
Q2 		$11.5K Buy
11,465
+1,444
+14% +$2.11K ﹤0.01% 2461
2024
Q1 		$19.8K Sell
10,021
-1,010
-9% -$1.75K ﹤0.01% 2445
2023
Q4 		$17.2K Buy
+11,031
New +$19.1K ﹤0.01% 2514

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM